• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Hemispherx Biopharma Inc

+ Add to Watchlist

HXB:GR

0.213 EUR 0.005 2.29%

As of 13:50:01 ET on 04/17/2014.

Company Profile for Hemispherx Biopharma Inc (HXB)

Hemispherx Biopharma, Inc. is a biopharmaceutical company that focuses on the development of nucleic acids to enhance the natural anti-viral defense systems of the human body. The Company's lead product, Ampligen, is undergoing clinical trials for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Contact Information

Hemispherx Biopharma Inc

1617 JFK Boulevard
Suite 660
Philadelphia, PA 19103
United States
Phone: 1-215-988-0080
Fax: 1-215-988-1739

Key Executives for Hemispherx Biopharma Inc (HXB)

William A CarterChairman/Pres/CEO/Chief Scientific OfcrThomas K EquelsVice Chair/CFO/Secy/Gen Cnsl
David R StrayerChief Medical Ofcr/Medical DirAdam PascaleChief Acctg Officer/Controller
Wayne S SpringateSenior VP:OperationsRalph Christopher CavalliVP:Quality Control

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil